Emodin Inhibited Pathological Cardiac Hypertrophy in Response to Angiotensin-Induced Hypertension and Altered the Gut Microbiome

Objective: Evidence suggests that food bioactives affect the epigenome to prevent pathological cardiac hypertrophy. Recently, we showed that emodin, an anthraquinone, attenuated pathological cardiac hypertrophy and histone deacetylase (HDAC) activity. However, we only examined the cardioprotective e...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Levi, Price, Tori, Hubert, Nathaniel, Moore, Julia, Shen, Yiqui, Athukorala, Maheshi, Frese, Steven, Martinez-Guryn, Kristina, Ferguson, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526847/
https://www.ncbi.nlm.nih.gov/pubmed/37759673
http://dx.doi.org/10.3390/biom13091274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526847/
https://www.ncbi.nlm.nih.gov/pubmed/37759673
http://dx.doi.org/10.3390/biom13091274

Ejemplares similares